Effect of Beetroot in reducing pain and hospitalization rate in sickle cell anemia

Investigating the effectiveness of Beetroot on reducing pain and the hospitalization rate of children with sickle cell anemia

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230410057871N5

Enrollment

Registered

2024-11-25

Start date

2024-11-21

Completion date

Unknown

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sickle cell anemia. Hb-SS disease with crisis

Interventions

Intervention 1: First intervention group: This group includes children aged 1 to 3 years, for which half of a beetroot capsule is prescribed daily. Intervention 2: Second intervention group: This grou

in the form of capsules with the same size, color and size as the beetroot capsule.

Eligibility

Sex/Gender

All

Age

No minimum to 15 Years

Inclusion criteria

Inclusion criteria: Children with sickle cell anemia up to 15 years old

Exclusion criteria

Exclusion criteria: Any underlying disease Pregnancy Patients with other hematologic disease Drug intolerance drug sensitivity

Design outcomes

Primary

Measure	Time frame
Change in the pain reported by the patient. Timepoint: 2 hours after the drug administration. Method of measurement: Visual Analogue Scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactArian Karimi Rouzbahani

Khoram-Abad University of Medical Sciences

arian.karimi@sbmu.ac.ir+98 930 675 7977

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026